|1.||Hoener, Marius C: 1 article (07/2015)|
|2.||Liechti, Matthias E: 1 article (07/2015)|
|3.||Rickli, Anna: 1 article (07/2015)|
|4.||Kopf, Simone: 1 article (07/2015)|
|5.||James, David: 1 article (12/2014)|
|6.||Thompson, John P: 1 article (12/2014)|
|7.||Hill, Simon L: 1 article (12/2014)|
|8.||Eddleston, Micheal: 1 article (12/2014)|
|9.||Cooper, Gillian: 1 article (12/2014)|
|10.||Vale, Allister: 1 article (12/2014)|
|1.||Breast Neoplasms (Breast Cancer)
07/01/2006 - "Over 40 cyclopenta[b]benzofurans have been tested against different human cancer cell lines, and the cumulative results provide some important clues as to how to improve their activity through modification of their chemical structures. "
07/01/2006 - "Based on the published data thus far, cyclopenta[b]benzofurans offer excellent potential as therapeutic agent candidates in cancer chemotherapy, even if much work still remains to be done for their further development."
07/01/2006 - "Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy."
07/01/2011 - "The antiproliferative effect of eleven neolignans, two lignans and one diterpene isolated from three Lauraceae plants, four benzofurans and two bicyclooctanes synthetic derivatives was evaluated in vitro on a set of five human cancer cells from solid tumors with a high incidence in Colombia. "
06/01/1997 - "Two related 1H-2,3,3a,8b-tetrahydrocyclopenta[b]benzofurans, aglafolin (1a) and rocaglamide (2), isolated from the stems of Aglaia elliptifolia, showed significant cytotoxicity in six cancer cell lines. "
|3.||Demyelinating Diseases (Demyelinating Disease)
06/01/1993 - "Blocking of potassium channels in Ranvier nodes by 4,5,6,7-substituted benzofurans and its significance on demyelinating diseases."
08/01/1994 - "Mode of action of psoralens, benzofurans, acridinons, and coumarins on the ionic currents in intact myelinated nerve fibres and its significance in demyelinating diseases."
12/01/2014 - "Comparing the 57 patients who reported ingesting benzofuran compounds alone with 315 patients ingesting mephedrone alone, benzofurans were more often associated with stimulant features, including tachycardia, hypertension, mydriasis, palpitation, fever, increased sweating, and tremor, (72% vs. 38%, odds ratio [OR] 4.2, 95% confidence interval [CI] 2.27-7.85, P < 0.0001) and mental health disturbances (58% vs. 38%, OR 2.3, 95% CI 1.29-4.07, P = 0.006). "
|1.||5-HT2B Serotonin Receptor
|3.||Potassium Channels (Potassium Channel)
|1.||Drug Therapy (Chemotherapy)